Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Nicholas W. Carris"'
Autor:
Nicholas W. Carris, Rahul Mhaskar, Emily Coughlin, Easton Bracey, Srinivas M. Tipparaju, Ganesh V. Halade
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Heart failure with preserved ejection fraction (HFpEF) is a syndrome with a heterogeneous cluster of causes, including non-resolving inflammation, endothelial dysfunction, and multi-organ defects. The present study’s objective w
Externí odkaz:
https://doaj.org/article/eec04d2235bc465cbd4bbdfeb9a70ec0
Publikováno v:
Pharmacy, Vol 11, Iss 1, p 13 (2023)
BACKGROUND: Team-based learning (TBL) encourages learners to think critically to solve problems they will face in practice. Pharmacokinetic dosing and monitoring are complex skills requiring the application of learned knowledge. The study sought to a
Externí odkaz:
https://doaj.org/article/65393f48d01d481196a279eab1c98b8c
Autor:
Kevin Cowart, Angelina Vascimini, Ambuj Kumar, Athanasios Tsalatsanis, Yalda Saba, Nicholas W. Carris
Publikováno v:
Clinical Diabetes. 41:147-153
The American Diabetes Association’s Standards of Medical Care in Diabetes emphasize the need for awareness regarding overbasalization (basal insulin doses >0.5 units/kg/day without bolus insulin) in the treatment of type 2 diabetes. However, outcom
Publikováno v:
Clinical Therapeutics. 45:248-261
Publikováno v:
Journal of Pharmacy Technology. 38:283-288
Background: Depression and obesity have a bidirectional relationship making the management of one, without the other, problematic. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a preferred medication class for diabetes and obesity treatme
Publikováno v:
Diabetes, Obesity and Metabolism. 24:348-353
Autor:
Nicholas W. Carris, Farah Abdeen, Wendy H. Updike, Rachel Franks, Faizah Saber, Derek D Balazy, Olivia Pane
Publikováno v:
Drugs. 81:881-893
The obesity and type 2 diabetes mellitus epidemics demonstrate that simply emphasizing a healthy lifestyle is insufficient. While weight loss medications have historically been considered “cosmetic”, glucagon-like peptide-1 receptor agonists (GLP
Autor:
Kevin Cowart, Nicholas W. Carris
Publikováno v:
Clin Diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d602f7df96e2f9e749c765adb6b9ac5
https://europepmc.org/articles/PMC8865788/
https://europepmc.org/articles/PMC8865788/
Autor:
Jaime Corvin, Nicholas W. Carris
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 28(2)
Autor:
Nicholas W. Carris, Eric Dietrich
Publikováno v:
The Annals of pharmacotherapy. 56(2)